الرسائل الموجهة للمختصين الصحيين
| المنتج | التاريخ | معلومات السلامة | المرفقات |
|---|---|---|---|
| Kytril ® - granisetron |
Risk of QTc prolongation |
||
| Aclasta® - zoledronic acid |
Risk of acute renal impairment |
||
| Yasmin® - drospirenone and ethinyl estradiol |
Risk of venous thromboembolism ( VTE ) |
||
| Tygacil® - tigecycline |
Increase in mortality |
||
| Arava® -leflunomide |
Risk of serious birth defects when administered during pregnancy |
